Results 21 to 30 of about 25,256 (244)

Response to Levetiracetam Treatment and Long-Term Follow-Up in Dogs With Reactive Seizures Due to Probable Exogenous Toxicity

Frontiers in Veterinary Science, 2021
Limited information is available on the long-term follow-up and seizure recurrence in dogs with reactive seizures due to suspected exogenous toxicity.
Fabio Stabile, Luisa De Risio
doaj   +1 more source

The Pharmacokinetics of Levetiracetam in Critically Ill Adult Patients: An Intensive Care Unit Clinical Study

Applied Sciences, 2022
The aim of this study was to investigate levetiracetam pharmacokinetics in critically ill adult intensive care patients and to identify pathophysiological factors affecting its kinetics.
Sophia-Liberty Markantonis, Nikolaos Markou, Apostolos Karagkounis, Dionysia Koutrafouri, Helen Stefanatou, Rania Kousovista, Vangelis Karalis   +6 more
doaj   +1 more source

Effects of Levetıracetam Treatment on the Autonomic Nervous System Functions in Epilepsy Patients

Archives of Epilepsy, 2020
Objectives:Sudden unexpected death in epilepsy patients is considered to be the most significant epilepsy-related cause of death, and this is associated especially with uncontrolled generalized tonic-clonic seizures, cardiac arrhythmia, decreased heart ...
Dilek YILMAZ, Burhanettin ÇİĞDEM
doaj   +1 more source

Epilepsy outcomes with immediateand extended-release levetiracetam in idiopathic generalized seizures [PDF]

Romanian Journal of Neurology
Idiopathic generalized epilepsy is a neurological disorder characterized by recurrent seizure attacks associated with sudden loss of consciousness. Seizures may present as generalized tonic-clonic or myoclonic episodes and require long-term antiseizure ...
Rana Hani Mohammed Ali Al-Shaikh Hamed, Asia Abed Al-Mahmood, Hiba Hani Mohammed Ali, Raad Ahmed Hussein, Muhammed Hameed Faeadh Hsn Al Jumaily   +4 more
doaj   +1 more source

Hallucination: A rare complication of levetiracetam theraphy

İstanbul Kuzey Klinikleri, 2017
Levetiracetam is a new antiepileptic drug. In addition to epilepsy, it is also used for treating anxiety disorders and dystonia as well as tardive dyskinesia associated with the use of levodopa and neuroleptic drugs.
Seher Erdogan, Mehmet Bosnak
doaj   +1 more source

Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs

Health Technology Assessment, 2021
Background: Levetiracetam (Keppra®, UCB Pharma Ltd, Slough, UK) and zonisamide (Zonegran®, Eisai Co. Ltd, Tokyo, Japan) are licensed as monotherapy for focal epilepsy, and levetiracetam is increasingly used as a first-line treatment for generalised ...
Anthony G Marson, Girvan Burnside, Richard Appleton, Dave Smith, John Paul Leach, Graeme Sills, Catrin Tudur-Smith, Catrin O Plumpton, Dyfrig A Hughes, Paula R Williamson, Gus Baker, Silviya Balabanova, Claire Taylor, Richard Brown, Dan Hindley, Stephen Howell, Melissa Maguire, Rajiv Mohanraj, Philip EM Smith   +18 more
doaj   +1 more source

Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam [PDF]

E3S Web of Conferences, 2020
Over the past few decades, many patients around the world have suffered from epilepsy, and epilepsy treatment is a long-term process. Thus, the safety and efficacy of medication for epilepsy are of equal importance.
Wang Wei
doaj   +1 more source

Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review

Journal of Pediatrics Review, 2016
Context Recently, new anti-epileptic drugs are marketed to be used as an add-on to the traditional drugs in children with refractory epilepsy.
Ali Abbaskhanian, Soheila Shahmohammadi
doaj   +2 more sources

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam [PDF]

Journal of Movement Disorders, 2014
Myoclonus in corticobasal degeneration (CBD) has often been associated with severe and difficult to treat disabilities. Levetiracetam is a new antiepileptic agent with antimyoclonic effects. Herein, we present a 72-year-old woman with clinically probable
Jae Wook Cho, Jae Hyeok Lee
doaj   +1 more source

Hallucination in a Seizure Patient Using Levetiracetam: A Case Report

Case Reports in Medicine, 2012
Levetiracetam, a relatively new antiepileptic drug (AED), is used mainly as adjuvant and less as monotherapy of seizure. Though rare, Levetiracetam is reported to induce hallucination.
D. R. Shakya, A. Dutta, R. Gautam
doaj   +1 more source